Platelet Glycoprotein GPIIb-IIIa Complex
Concept
Vocabulary Service
Overview
subject area of
-
A Barbourin-albumin Fusion Protein that Is Slowly Cleared In Vivo Retains the Ability to Inhibit Platelet Aggregation In Vitro Academic Article
-
A simple and rapid competitive enzyme-linked immunosorbent assay to identify HPA-1a (PlA1)-negative donor platelet units Academic Article
-
ABH antigens on human platelets: Expression on the glycosyl phosphatidylinositol-anchored protein CD109 Academic Article
-
Activated Clotting Time to Guide Heparin Dosing in Non–ST-Segment–Elevation Acute Coronary Syndrome Patients Undergoing Percutaneous Coronary Intervention and Treated With IIb/IIIa Inhibitors Academic Article
-
Analyses of cellular multimerin 1 receptors: in vitro evidence of binding mediated by αΙΙbβ3 and αvβ3 Academic Article
-
Angina (unstable). Academic Article
-
Angina (unstable). Academic Article
-
Angina (unstable). Academic Article
-
Anticoagulation With Otamixaban and Ischemic Events in Non–ST-Segment Elevation Acute Coronary Syndromes Academic Article
-
Antiplatelet Drugs Academic Article
-
Antiplatelet Drugs Academic Article
-
Antiplatelet drugs Academic Article
-
Antithrombotic Therapy in Patients Undergoing Coronary Angioplasty Academic Article
-
Antithrombotic Therapy in Patients Undergoing Percutaneous Coronary Intervention Academic Article
-
Appropriate antiplatelet and antithrombotic therapy in patients with acute coronary syndromes: recent updates to the ACC/AHA guidelines. Academic Article
-
Beyond Heparin and Aspirin Academic Article
-
Bivalirudin Academic Article
-
Comparative efficacy of fibrinogen and platelet supplementation on the in vitro reversibility of competitive glycoprotein IIb/IIIa (αIIb/β3) receptor-directed platelet inhibition Academic Article
-
Comparative efficacy of fibrinogen and platelet supplementation on the in vitro reversibility of competitive glycoprotein IIb/IIIa receptor-directed platelet inhibition Academic Article
-
Comparison of bivalirudin versus heparin during percutaneous coronary intervention (the Randomized Evaluation of PCI Linking Angiomax to Reduced Clinical Events [REPLACE]-1 trial) Academic Article
-
Comparison of degree of platelet inhibition by abciximab versus tirofiban in patients with unstable angina pectoris and non–Q-wave myocardial infarction undergoing percutaneous coronary intervention Academic Article
-
Comparison of the effect of coagulation and platelet function
impairments on various mouse bleeding models Academic Article
-
Dark Chocolate Effect on Platelet Activity, C-Reactive Protein and Lipid Profile: A Pilot Study Academic Article
-
Decreasing Mortality With Primary Percutaneous Coronary Intervention in Patients With Acute Myocardial Infarction: The Mayo Clinic Experience From 1991 Through 1997 Conference Paper
-
Drug-Induced Immune-Mediated Thrombocytopenia — From Purpura to Thrombosis Academic Article
-
Economic issues in glycoprotein IIb/IIIa receptor therapy Academic Article
-
Effect of abciximab on late adverse events in patients with diabetes mellitus undergoing stent implantation Academic Article
-
Efficacy and Safety of Fondaparinux Versus Enoxaparin in Patients With Acute Coronary Syndromes Treated With Glycoprotein IIb/IIIa Inhibitors or Thienopyridines Academic Article
-
Efficacy and safety of a routine early invasive strategy after fibrinolysis stratified by glycoprotein IIb/IIIa inhibitor use during percutaneous coronary intervention: a pre-specified subgroup analysis of the TRANSFER-AMI randomised controlled trial Academic Article
-
Efficacy and safety of clopidogrel pretreatment before percutaneous coronary intervention with and without glycoprotein IIb/IIIa inhibitor use Academic Article
-
Ethanol enhances the inhibitory effect of an oral GPIIb/IIIa antagonist on human platelet function Academic Article
-
Evaluation of the role of abciximab (Reopro) as a rescue agent during percutaneous coronary interventions: In-hospital and six-month outcomes Academic Article
-
From guidelines to clinical practice: the impact of hospital and geographical characteristics on temporal trends in the management of acute coronary syndromes The Global Registry of Acute Coronary Events (GRACE) Academic Article
-
Glycoprotein IIb/IIIa Receptor Therapy in Percutaneous Coronary Intervention and Non???ST-Segment Elevation Acute Coronary Syndromes Academic Article
-
HUMAN PLATELET THROMBIN RECEPTORS Academic Article
-
IIb or not IIb: When, how, and which GP IIb/IIIa inhibitor? Academic Article
-
Inhibition of Microsurgical Thrombosis by the Platelet Glycoprotein IIb/IIIa Antagonist SR121566A Academic Article
-
Inhibition of platelet-dependent prothrombinase activity and thrombin generation by glycoprotein IIb/IIIa receptor-directed antagonists: potential contributing mechanism of benefit in acute coronary syndromes. Academic Article
-
Inhibition of the Platelet Glycoprotein IIb/IIIa Receptor with Tirofiban in Unstable Angina and Non–Q-Wave Myocardial Infarction Academic Article
-
Management strategies in unstable coronary artery disease-Current problems and future directions Academic Article
-
New Antithrombotic Agents Academic Article
-
Novel dosing regimen of eptifibatide in planned coronary stent implantation (ESPRIT): a randomised, placebo-controlled trial Academic Article
-
Performance characteristics of platelet autoantibody testing for the diagnosis of immune thrombocytopenia using strict clinical criteria Academic Article
-
Platelet activation induced by porcine factor VIII (HYATE:C) Academic Article
-
Platelet-Active Drugs Academic Article
-
Platelet-Active Drugs: The Relationships Among Dose, Effectiveness, and Side Effects Academic Article
-
Platelet-active drugs : the relationships among dose, effectiveness, and side effects. Academic Article
-
Platelet-active drugs: the relationships among dose, effectiveness, and side effects. Academic Article
-
Platelets release pathogenic serotonin and return to circulation after immune complex-mediated sequestration Academic Article
-
Preventing thrombosis: update of first-line therapy in the management of non-ST segment elevation acute coronary syndromes. Academic Article
-
Radial versus femoral access for emergent percutaneous coronary intervention with adjunct glycoprotein IIb/IIIa inhibition in acute myocardial infarction—the RADIAL-AMI pilot randomized trial Academic Article
-
Recombinant albumins containing additional peptide sequences smaller than barbourin retain the ability of barbourin-albumin to inhibit platelet aggregation Academic Article
-
Recommendations for the implementation of platelet autoantibody testing in clinical trials of immune thrombocytopenia Academic Article
-
Routine vs Selective Invasive Strategies in Acute Coronary Syndromes Academic Article
-
Stenting and glycoprotein IIb/IIIa inhibition in patients with acute myocardial infarction undergoing percutaneous coronary intervention: Findings from the global registry of acute coronary events (GRACE) Academic Article
-
The Editor's Roundtable: Arterial Thrombosis and Acute Coronary Syndromes Academic Article
-
The IgG subclasses of platelet-associated autoantibodies directed against platelet glycoproteins IIb/IIIa in patients with idiopathic thrombocytopenic purpura Academic Article
-
The effect of rituximab on anti‐platelet autoantibody levels in patients with immune thrombocytopenia Academic Article
-
The platelet cytoskeleton stabilizes the interaction between αIIbβ3 and its ligand and induces selective movements of ligand-occupied integrin Article
-
The use of glycoprotein IIb/IIIa receptor inhibitors in unstable angina. Academic Article
-
Thrombocytopenia associated with the use of GPIIb/IIIa inhibitors: position paper of the ISTH working group on thrombocytopenia and GPIIb/IIIa inhibitors Academic Article
-
Thrombocytopenia in Patients With an Acute Coronary Syndrome (from the Global Registry of Acute Coronary Events [GRACE]) Academic Article
-
Treating Patients With Acute Coronary Syndromes With Aggressive Antiplatelet Therapy (from the Global Registry of Acute Coronary Events) Academic Article
-
Underutilization of clopidogrel and glycoprotein IIb/IIIa inhibitors in non–ST-elevation acute coronary syndrome patients: The Canadian Global Registry of Acute Coronary Events (GRACE) experience Academic Article
-
Unstable angina. Academic Article
-
Unstable angina. Academic Article
-
Use of Heparins in Non-ST-Elevation Acute Coronary Syndromes Academic Article
-
Which antithrombotic to use during PCI? Academic Article